---
title: "StentIt launches first-in-human trial of bioresorbable stent to treat below-the-knee CLTI"
date: "2025-06-30T09:14:48.000Z"
publishedDate: "30 juin 2025"
summary: "StentIt has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischaemia (CLTI) below the knee have successfully been treated using the RFS implant."
importance: ""
sourceUrl: "https://vascularnews.com/stentit-launches-first-in-human-trial-of-bioresorbable-stent-to-treat-below-the-knee-clti/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-06-30-stentit-launches-first-in-human-trial-of-bioresorbable-stent-to-treat-below-the-knee-clti"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/06/StentIt-technology.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/stentit-launches-first-in-human-trial-of-bioresorbable-stent-to-treat-below-the-knee-clti/"
---

![StentIt launches first-in-human trial of bioresorbable stent to treat below-the-knee CLTI](https://vascularnews.com/wp-content/uploads/sites/7/2025/06/StentIt-technology.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/stentit-launches-first-in-human-trial-of-bioresorbable-stent-to-treat-below-the-knee-clti/*

## L’essentiel

StentIt has announced the successful implantation of its Resorbable Fibrillated Scaffold (RFS). As part of the VITAL-IT 1 study, patients with chronic limb-threatening ischaemia (CLTI) below the knee have successfully been treated using the RFS implant.

## Lien source

https://vascularnews.com/stentit-launches-first-in-human-trial-of-bioresorbable-stent-to-treat-below-the-knee-clti/
